Android app on Google Play

BofA/Merrill Lynch Upgrades Achillion Pharmaceuticals (ACHN) to Buy

September 19, 2012 6:28 AM EDT Send to a Friend
Get Alerts ACHN Hot Sheet
Price: $2.83 --0%

Rating Summary:
    8 Buy, 6 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Trade ACHN Now!
Join SI Premium – FREE
BofA/Merrill Lynch upgraded Achillion Pharmaceuticals (NASDAQ: ACHN) from Underperform to Buy.

For an analyst ratings summary and ratings history on Achillion Pharmaceuticals click here. For more ratings news on Achillion Pharmaceuticals click here.

Shares of Achillion Pharmaceuticals closed at $8.10 yesterday.




You May Also Be Interested In


Related Categories

Hot Upgrades, Upgrades

Related Entities

Merrill Lynch, Bank of America

Add Your Comment